Radioiodine based biomedical carriers for cancer theranostics
Authors:
- Jingru GuoJGJingru Guo
- Hehua XiongHXHehua Xiong
- Huihui LiuHLHuihui Liu
- Tao ZhangTZTao Zhang
- Xiaolian SunXSXiaolian Sun
- 11 September 2023
- journal article
- review article
- Published by Elsevier in Coordination Chemistry Reviews
- Vol. 497
Abstract
No abstract availableKeywords
This publication has 209 references indexed in Scilit:
- Radioiodine: The Classic Theranostic AgentSeminars in Nuclear Medicine, 2012
- The golden age: gold nanoparticles for biomedicineChemical Society Reviews, 2011
- 125I-Labeled Gold Nanorods for Targeted Imaging of InflammationACS Nano, 2011
- Molecular Theranostics: A Primer for the Imaging ProfessionalAmerican Journal of Roentgenology, 2011
- Nanoparticle-based theranostic agentsAdvanced Drug Delivery Reviews, 2010
- The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid CancerThyroid®, 2009
- Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-d-GEEEKNuclear Medicine and Biology, 2009
- Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distributionNuclear Medicine and Biology, 1999
- The standardization and measurement of decay scheme data of 124IInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992
- Study on the decay of iodine-123International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1987